Thrilled to have been part of the EURETINA’24 Congress in Barcelona!
BCN Peptides had an amazing time learning about the latest advancements in retinal care —from cutting-edge imaging equipment to AI autonomous systems and new metrics for disease characterization— and presenting the latest insights on Diabetic Retinopathy with top experts. It was inspiring to connect, learn, and contribute to the future of Ophthalmology!
Thanks to the Organizing Committee for such an inspiring event. We are already looking forward to EURETINA’25 in Paris!
BCN Peptides has contributed to expanding the insights on Diabetic Retinopathy by giving an oral presentation.
#EURETINA #EURETINA’24 #Ophthalmology #Retina #DiabeticRetinopathy #Innovation #Networking #BCNPeptides
We’re excited to announce that BCN Peptides will be attending CPHI Milan 2024, one of the leading global events in the pharmaceutical industry! We will showcase our latest innovations from October 8th to 10th at the Fiera Milano venue. This year, we are especially proud to present our brand new facility, designed to significantly enhance our peptide production capabilities and meet the growing demand for innovative peptide-based solutions.
👥 Meet Us at Stand 24C49
Attendees will have the chance to engage in outstanding conversations with our Sales Department at Stand 24C49. We’re eager to discuss how BCN Peptides can support your R&D needs with our state-of-the-art advancements in peptide synthesis, personalized medicine, and other groundbreaking offerings. Whether you’re looking for high-quality customised peptide solutions or are interested in exploring collaborative opportunities, we are ready to offer tailored solutions to fit your needs.
🔬 Showcasing Innovation and Expertise
During CPHI Milan, we will highlight our extensive experience in producing complex peptides. Additionally, we will showcase our innovative approaches to peptide therapeutics. The insights we gain from this event will further enhance our ability to support our clients in their research and development efforts. This, in turn, helps bring groundbreaking peptide-based solutions to market.
🤝 A Unique Opportunity to Connect
This event offers more than just innovation insights. It’s a chance to connect, exchange ideas, and discuss the future of the pharmaceutical industry. Our Sales team is eager to dive into conversations, answer your questions, and explore how our expertise can help you achieve your goals.
📅 Let’s Schedule a Meeting during the event!
Whether you’re exploring partnership opportunities or lcustomised solutions, we’re excited to discuss how BCN Peptides can support your projects.
🔗 Want to schedule a formal meeting? Reach out to us directly by email at info@bcnpeptides.com or through LinkedIn, and let’s make it happen. We will schedule time to discuss your specific needs and how BCN Peptides can deliver the innovation you’re seeking.
Don’t miss out – we look forward to seeing you in Milan!
#BCNPeptides #CPHI2024 #Milan2024 #PharmaceuticalIndustry #PeptideScience #Innovation #Biotechnology #NewFacility #PeptideTherapeutics #Collaboration #ResearchAndDevelopment #OneMonthToGo #Stand24C49
BCN Peptides joins the Boulder Peptide Symposium in Colorado.
BCN Peptides is thrilled to announce our participation in the upcoming Boulder Peptide Symposium, happening in Colorado from September 16th to 19th, 2024. As one of the leading gatherings for the global peptide community, this event brings together industry leaders, scientists, and researchers to explore the latest trends and innovations in peptide science.
The Boulder Peptide Symposium, known for its focus on cutting-edge research and technological advancements, offers a unique platform for professionals from academia and industry. Here, attendees can network, share insights, and collaborate on the future of peptide-based therapies and technologies.
At BCN Peptides, we consistently prioritize advancing peptide science. We also strive to deliver high-quality, customised solutions that meet the specific needs of our clients. Our Sales Area Manager, Dr. Marina Pascual, will be on-site, ready to engage in meaningful discussions and explore new opportunities for collaboration.
During the symposium, we plan to highlight our extensive experience in producing complex peptides. Additionally, we will showcase our innovative approaches to peptide therapeutics. The insights we gain from this event will further enhance our ability to support our clients in their research and development efforts. This, in turn, helps bring groundbreaking peptide-based solutions to market.
By attending the Boulder Peptide Symposium, we ensure that BCN Peptides remains at the forefront of the peptide industry and we stay updated on the latest scientific research and technological advancements. Our participation not only underscores our commitment to driving innovation but also highlights our dedication to excellence in peptide science.
We are eager to see the collaborations and connections that will emerge from this event. If you’re attending, be sure to connect with us during the symposium. Whether you’re interested in our cutting-edge peptide synthesis capabilities, our research in peptide-based personalised medicine, or exploring potential partnerships, we’re excited to meet you.
Stay tuned for updates as the event approaches.
We look forward to seeing you in Colorado!
#BCNPeptides #BoulderPeptideSymposium #PeptideScience #Innovation #Biotechnology #ResearchAndDevelopment #Colorado2024 #PeptideTherapeutics #Collaboration #ExcellenceInScience
🎉 Celebrating Excellence in Peptide Research! 🎉
We proudly announce that Dr. César de la Fuente, from Penn University received the prestigious Miklós Bodánszky Award, presented by the European Peptide Society and sponsored by BCN Peptides.
Dr. de la Fuente is internationally recognised for his pioneering work in using the power of machines to accelerate discoveries in biology and medicine. Specifically, he developed the first computer-designed antibiotic with proven efficacy in animal models, showcasing the application of AI in antibiotic discovery and helping to launch this emerging field. This award highlights his commitment and significant contributions to advancing peptide science and biotechnology.
At BCN Peptides, we are passionate about driving research and development in the field of peptides, and it is an honor to support this award that recognises scientific excellence. Our commitment to innovation and collaboration motivates us to continue supporting great talents, like Dr. de la Fuente, who are making a difference in science and medicine.
Congratulations, Dr. César de la Fuente, on this well-deserved Miklós Bodánszky Award recognition! 👏
hashtag#MiklósBodánszkyAward hashtag#PeptideScience hashtag#AIinBiotech hashtag#Innovation hashtag#ResearchAndDevelopment hashtag#CesarDeLaFuente hashtag#PennUniversity hashtag#Biotechnology hashtag#BCNPeptides hashtag#EuropeanPeptideSociety